{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:29:00Z","timestamp":1777408140251,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jcrc.2011.12.005","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T13:15:15Z","timestamp":1328102115000},"page":"528.e7-528.e14","source":"Crossref","is-referenced-by-count":26,"title":["Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically Ill patients"],"prefix":"10.1016","volume":"27","author":[{"given":"Mark A.","family":"Malesker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Hilleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2011.12.005_bb0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pcad.2006.02.004","article-title":"Clinical features in the management of selected hypertensive emergencies","volume":"48","author":"Elliott","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0010","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-200868030-00003","article-title":"Treatment of acute severe hypertension","volume":"68","author":"Varon","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.06-2490","article-title":"Hypertensive crises: challenges and management","volume":"131","author":"Marik","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1592\/phco.30.11.1087","article-title":"Patterns of antihypertensive treatment in patients with acute severe hypertension from a nonneurologic cause: Studying the Treatment of Acute Hypertension (STAT) Registry","volume":"30","author":"Devlin","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1751-7176.2009.00196.x","article-title":"Treatment of hypertension in the inpatient setting: use of IV labetalol and hydralazine","volume":"12","author":"Weder","year":"2010","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0035","first-page":"992","article-title":"Postoperative hypertension: a prospective, placebo-controlled, randomized, double-blind trial, with intravenous nicardipine hydrochloride","volume":"41","author":"Halpern","year":"1990","journal-title":"Angiology"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1053-0770(97)90206-8","article-title":"Intravenous nicardipine in the treatment of postoperative arterial hypertension","volume":"11","author":"Vincent","year":"1997","journal-title":"J Cardiothoracic Vasc Anesth"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0885066604271619","article-title":"A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage","volume":"20","author":"Qureshi","year":"2005","journal-title":"J Intensive Care Med"},{"issue":"suppl 2","key":"10.1016\/j.jcrc.2011.12.005_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.1979.tb04787.x","article-title":"Labetalol infusion in acute myocardial infarction with systemic hypertension","volume":"8","author":"Marx","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0055","first-page":"68","article-title":"Labetalol and esmolol in the control of hypertension after intracranial surgery","volume":"70","author":"Muzzi","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0060","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/00000539-200010000-00024","article-title":"A comparative study between a calcium channel blocker (nicardipine) and a combined alpha-beta blocker (labetalol) for control of emergence hypertension during craniotomy for tumor surgery","volume":"91","author":"Kross","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.57.1.18","article-title":"Autoregulation of cerebral blood flow surrounding acute intracerebral hemorrhage","volume":"57","author":"Powers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12028-008-9057-z","article-title":"A comparison of nicardipine and labetalol for acute hypertension management following stroke","volume":"9","author":"Liu-Deryke","year":"2008","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0075","author":"Liu-Deryke","year":"2010"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00134-002-1406-3","article-title":"Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol","volume":"28","author":"Elastrous","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0085","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.annemergmed.2010.06.146","article-title":"CLUE: a comparative effectiveness trial nicardipine versus labetalol in the emergency department","volume":"56","author":"Peacock","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jcrc.2011.12.005_bb0090","unstructured":"Treatment Guidelines from the Medical Letter. Cardiovascular drugs in the ICU. 2002; 1: 19-24."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944111005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944111005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T12:53:51Z","timestamp":1543236831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944111005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0883944111005041"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2011.12.005","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}